Man

Sergio Agustín Mezzano Abedrapo

Catedratico

Universidad Austral de Chile

Valdivia, Chile

Líneas de Investigación


Mecanismos celulares y moleculares de fibrosis e inflamación en nefropatías: Rol de Gremlin Inmunopatogenia de enfermedades glomerulares Progresión de Enfermedad Renal Crónica Nefropatía Diabética: Microambiente inflamatorio y mecanismos progresión.

Educación

  •  Medicina Interna, Nefrología, CONACEM. Chile, 1987
  •  Fellow American College of Physicians, American College of Physicians.. Estados Unidos, 2001
  •  Fellow American Society of Nephrology, American Society of Nephrology. Estados Unidos, 2004
  •  Especialista en Medicina Interna, UNIVERSIDAD AUSTRAL DE CHILE. Chile, 1975
  •  Post doctoral research fellow Nephrology, Universidad de Cincinnati. Estados Unidos, 1982

Experiencia Académica

  •   Profesor Asistente Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1979 - 1984

  •   Beca Investigación en Nefrología clínica Full Time

    Universidad de Cincinnati

    Medicina

    Cincinnati, Estados Unidos

    1980 - 1982

  •   Jefe de Departamento Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1983 - 1987

  •   Profesor Asociado Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1984 - 1990

  •   Profesor Titular Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1990 - 2009

  •   Director Oficina de Investigación Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    1990 - 2000

  •   Jefe Unidad de Nefrología Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    2001 - At present

  •   Profesor Catedrático Full Time

    UNIVERSIDAD AUSTRAL DE CHILE

    Medicina

    Valdivia, Chile

    2009 - At present

  •   Profesor Visitante Full Time

    Universidad de Torino

    Hospital Giovanni Batista Molinette

    Torino, Italia

    1991 - 1991

  •   Profesor Visitante Full Time

    Rockefeller University

    Medicina

    New York, Estados Unidos

    1988 - 1988

Experiencia Profesional

  •   Medico Tratante Medicina Interna Full Time

    Servicio Nacional de Salud

    Valdivia, Chile

    1975 - 1979

  •   Medico Tratante Unidad de Cuidados Intensivos Part Time

    Servicio Nacional de Salud

    Valdivia, Chile

    1975 - 1979

  •   Director Médico Valdivia Other

    Nephrocare Fresenius Chile

    Valdivia, Chile

    2010 - At present

  •   Académico Convenio Docente Asistencial UACH-Servicio de Salud Valdivia Full Time

    Universidad Austral de Chile

    Valdivia, Chile

    1982 - At present

Formación de Capital Humano


1. Como Profesor de Medicina Interna y Nefrología, desde año 1985, he participado como profesor Responsable y Profesor Colaborador en Cursos de Semiología, Clínica Médica, Internado de Medicina y particularmente como Responsable Curso de Nefrología, a alumnos de pregrado, Escuela de Medicina, UACH.

2. En mi calidad de Profesor Titular y Catedrático, y como Director del Programa Especialización en Nefrología desde 1995, he participado en la formación de los siguientes especialistas :Guillermo Rojas 1995; Claudio Flores 1997; Patricia Diaz 1998; Claudio Aros 1999;; Rocío Sáenz 2002; Carolina Muñoz 2004; Herman Schneider 2004; Alejandra Carrasco 2006; Erick Zúñiga 2007; Jorge H. Mukdsi 2007; Javier Ramírez 2008; Guisselle Carvajal 2008; Fernando Pereira 2008; Mauricio Álvarez 2009; Juan Velásquez 2010; Andrea Hernández 2010; Gustavo Jeldres 2011; Francisca Carriquiry 2011; Marcelo Salvatici 2009; Rodrigo Mansilla Barrientos 2012; Celeste Fulgeri 2013; Alexander Ballesteros 2013; Rodrigo Cortez 2015; Lizzy Orellana 2015; Daniela Ubilla 2017; Francisco García 2018; Patricio Herrera 2018; Marina Leiva 2019; Gustavo Navarro 2019; Rodolfo Carmona 2019; Carolina Wittwer 2020 y Francisco Rodríguez 2020.

3. Profesor Responsable Programa Doctorado Ciencias Médicas, habiendo colaborado en la formación de al menos 10 alumnos del programa y como Patrocinante o Copatrocinante de 6 alumnos de dicho Programa: Dra. Alejandra Droguett; Dra. Carolina Lavoz; Dra. Paola Krall; Dr. Lucas Opazo; Dra. Vanessa Marchant y candidato a Doctor Marcelo Aguilar


Difusión y Transferencia


Durante mi vida académica he siso invitado como conferenciante y profesor visitante a numerosos congresos y diferentes servicios de nefrología entre los cuales destaco el Congreso Chileno de Nefrología, Congreso Latinoamericano de Nefrología, Congreso Americano de Nefrología (Renal Week) y Congreso Mundial de Nefrología.
Listado de conferencias últimos 5 años:
99. Nuevos aspectos clínicos y patogénicos del síndrome nefrítico. I Congreso Internacional de Nefrología, 20-22 Febrero 2015, Quito, Ecuador
100. Nefropatía Diabética patogénica prevención y tratamiento. I Congreso Internacional de Nefrología, 20-22 Febrero 2015, Quito, Ecuador
101. Nefropatía Membranosa: Tratamiento. VIII Congreso Paraguayo de Nefrología 23-25 Septiembre 2015, Asunción, Paraguay
102. Nefropatía Diabética: Cómo evitamos la progresión. VIII Congreso Paraguayo de Nefrología, 23-25 Septiembre 2015, Asunción, Paraguay
103. Presentación de casos clínicos de Enfermedades Glomerulares. VIII Congreso Paraguayo de Nefrología, 23-25 Septiembre 2015. Asunción Paraguay
104. Nefropatía Diabética: Nuevos aspectos patogénicos. XXXII Congreso Chileno Conjunto de las Sociedades de Nefrología e Hipertensión, 25- 28 Noviembre 2015, Viña del Mar, Chile
105. Mediadores de daño renal en paciente diabético. Primeras Jornadas Universitarias de Tecnología e innovación en diabetes, Universidad de Antofagasta, 4-7 de mayo 2016, Antofagasta, Chile
106. I Jornada de Fisiología Celular y Cáncer, Universidad Católica del Maule, Chile, 8 de noviembre 2017, Talca, Chile
107. Actualización en Glomerulonefritis. XLVIII Congreso Nacional de la Sociedad Española de Nefrología, IX Congreso Iberoamericano de Nefrología, 16-19 noviembre 2018, Madrid, España
108. Actualización de Nefropatía Diabética. XL Congreso Chileno Medicina Interna, 2-4 Septiembre 2019, Santiago Chile
109. Rol de la Inflamación en la Nefropatía Diabética. XXXVI Congreso de la Sociedad Chilena de Nefrología, Hipertensión y Trasplante. 16-18 Octubre 2019, Coquimbo, Chile


Premios y Distinciones

  •   Research Award

    ACADEMIA CHILENA DE MEDICINA

    Chile, 1999

    Premio a la Investigación

  •   International Medal Award

    National Kidney Foundation

    Estados Unidos, 2002

    Primer Nefrólogo chileno en obtener este reconocimiento por la National Kidney Foundation

  •   Presidente Sociedad Latinoamericana de Nefrología e Hipertensión

    Sociedad Latinoamericana Nefrología e Hipertension

    Chile, 2004

    Primer Presidente Chileno de la Sociedad Latinoamericana de Nefrología. Desde 2002 a 2004

  •   Miembro Consejo KDIGO

    Kidney Disease Improving Global outcomes

    Chile, 2003

    Miembro consejo asesor

  •   Co-editor

    Kidney International Edicion Española

    España, 2004

    Co-editor

  •   Miembro Comite Editorial

    Clinical Journal of The american Society of Nephrology

    Estados Unidos, 2005

    Miembro Comité editorial

  •   Premio Dr. Eduardo Katz

    Sociedad Chilena de Nefrología

    Chile, 2005

    Premio Trayectoria

  •   Laureate Award

    American College of Physicians. Chilean Charper

    Estados Unidos, 2007

    premio trayectoria

  •   Miembro de Honor

    Sociedad española de Nefrología

    España, 2007

    Miembro de honor

  •   Premio Dr. Victor Raul Miatello

    Sociedad Latinoamericana de Nefrología e Hipertension

    Chile, 2009

    Premio Trayectoria conferido por primera vez a un nefrólogo chileno

  •   Catedrático

    UNIVERSIDAD AUSTRAL DE CHILE

    Chile, 2010

    Premio Trayectoria Académica como uno de los cuatro catedráticos electos de la Universidad Austral de Chile, junto a los Drs. Manfred Mc Neef, esteban Rodríguez y Juan Carlos Slebe

  •   Premio Conferencia Sociedad Médica santiago

    Congreso Chileno de Medicina Interna

    Chile, 2011

    Premio Trayectoria

  •   Council Member

    International Society of Nephrology

    Estados Unidos, 2013

    Premio Trayectoria

  •   Miembro correspondiente

    Academia Chilena de Medicina

    Chile, 2002

    Conferencia de ingreso a la Academia Chilena de Medicina: Rol de la Proteinuria y Angiotensina II en la progresión de la enfermedad renal.

  •   Traveling Scholarship

    ACADEMIA CHILENA DE CIENCIAS

    Chile, 1988

    Beca para Estadía de investigación de 3 meses Universidad de Rockefeller, New York, USA

  •   Estadía de Investigación

    COMISION DE LAS COMUNIDADES EUROPEAS-CHILE

    Chile, 1992

    Estadía de 6 meses como Profesor visitante en la Universidad de Torino, Italia


 

Article (139)

Deletion of delta-like 1 homologue accelerates renal inflammation by modulating the Th17 immune response
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy
Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes
Could IL-17 be a Novel Therapeutic target in diabetic nephropathy?
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
Lipotoxicity an Diabetic Nephropathy:Novel Mechanistic insight and therapeuthic oportinities
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
VEGFR2 Blockage Improves Renal Damage in an Experimental Model of Tipe 2 Diabetic Nephropathy
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis
Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy
CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury
Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation
Gremlin activates the Notch pathway linked to renal inflammation
Gremlin and renal diseases: ready to jump the fence to clinical utility?
Gremlin regulates tubular epithelial to mesenchymal transition via VEGFR2: Potential role in renal fibrosis
Targeting inflammation in diabetc nephropathy: a tale of hope
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy
Mitogen-activated Ptotein Kinase 14 promotes AKI
The MEST score provides earlier risk prediction in IgA nephropathy
Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway
Lyso-Gb3 activates Notch1 in human podocytes
Up-regulation of the kinin B2 receptor pathway modulates the TGF-beta/Smad signaling cascade to reduce renal fibrosis induced by albumin
Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis
Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells
Translational study of the Notch pathway in hypertensive nephropathy
Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice
Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria
Fn14 in podocytes and proteinuric kidney disease
Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy
Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II
Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation
EFFECT OF EPLERENONE ON HYPERTENSION-ASSOCIATED RENAL DAMAGE IN RATS: POTENTIAL ROLE OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPAR-gamma)
Effect of eplerenone on hypertension-associated renal damage in rats: Potential role of peroxisome proliferator activated receptor gamma(PPAR-?)
The health system in Chile: the nephrologist perspective
Role of the kidney in salt sensitive hypertension
Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-beta-Independent Process
Suppressors of Cytokine Signaling Abrogate Diabetic Nephropathy
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults
Angiotensin-(1-7) and the G protein-coupled receptor Mas are key players in renal inflammation
Bariatric surgery in patients with focal segmental glomerulosclerosis secondary to obesity
Expression of gremlin, a bone morphogenetic protein antagonist, is associated with vascular calcification in uraemia
The MIF Receptor CD74 in Diabetic Podocyte Injury
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
Co-regulation of Gremlin and Notch signalling in diabetic nephropathy
Ethnic Differences in HLA Antigens in Chilean Donors and Recipients: Data From the National Renal Transplantation Program
Gremlin: A novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy
IHG-1 amplifies TGF-beta 1 signaling and is increased in renal fibrosis
Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways
Renal transplantation in Mapuche people
Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis
Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats
Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats
Long-term treatment with an ACE inhibitor or an AT(1) antagonist avoids hypertension-induced inflammation in the kidney
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney
Renal health in Chile
Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II
Antiphospholipid antibodies in idiopathic membranous nephropathy
Correlation between C2 and AUC (0-4) in renal transplant patients treated with diltiazem.
Early and sustained inhibition of nuclear factor-kappa B prevents hypertension in spontaneously hypertensive rats
Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy
Human leukocyte antigens in indigenous (Mapuche) people in a regional renal transplantation program in Chile
Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?
Late onset of familial nephrotic syndrome associated with a compound heterozygous mutation of the podocin-encoding gene.
Long-term blood pressure control prevents oxidative renal injury
No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.
Valsartan-induced hematocrit changes in renal transplant patients.
Angiotensin II, via AT(1) and AT(2) receptors and NF-kappa B pathway, regulates the inflammatory response in unilateral ureteral obstruction
NF-kappa B activation and overexpression of regulated genes in human diabetic nephropathy
Angiotensin II increases connective tissue growth factor in the kidney
Effect of simultaneous blockade of AT1 and AT2 receptors on the NF kappa B pathway and renal inflammatory response
Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage
Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney
Effect of mycophenolate mofetil on kallikrein expression in the kidney of 516 nephrectomized rats
Levofloxacin associated Achilles tendinitis. Report of four cases
Angiotensin II and renal fibrosis
Renin-angiotensin system and renal damage: Emerging data on angiotensin II as a proinflammatory mediator
Role of the renin-angiotensin system in vascular diseases - Expanding the field
Tubular NF-kappa B and AP-1 activation in human proteinuric renal disease
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo
Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis
Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study.
Anticardiolipin antibodies in classic pediatric hemolytic-uremic syndrome: A possible pathogenic role
Immunohistochemical localization of IL-8 and TGF-beta in streptococcal glomerulonephritis.
Modification of the Pharmacokinetics of Cyclosporine A and Metabolites by the Concomitant Use of Neoral and Diltiazem or Ketoconazol in Stable Adult Kidney Transplants
Study of neoral kinetics in adult renal transplantation treated with diltiazem.
Endothelial cell markers in chronic uremia: relationship with hemostatic defects and severity of renal failure.
Incidence and studies on antigenic specificities of antineutrophil-cytoplasmic autoantibodies (ANCA) in poststreptococcal glomerulonephritis
Role of streptococcal proteinase in acute post-streptococcal glomerulonephritis.
Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis
Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy
Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
Decreased platelet counts and decreased platelet serotonin in poststreptococcal nephritis.
Hepatitis C virus: results of detection in several high risk groups in the X region of Chile.
A study on the antigenic nature of circulating immune complexes in hemolytic uremic syndrome: no evidence of platelet membrane glycoproteins antigens
Detection of antineutrophil cytoplasmic antibodies in the classic form of hemolytic uremic syndrome
Hemolytic uremic syndrome in childhood : study of several factors otentially related with its genesis.
Antineutrophil cytoplasmic autoantibodies in poststreptococcal nephritis
Detection of platelet activating factor in plasma of patients with streptococcal nephritis.
Rapidly progressive glomerulonephritis without immune deposits: detection of neutrophil anticytoplasmic antibodies
Erythrocitosis associated to idiopathic membranous nephropathy. Case report
Failure to detect unique reactivity to streptococcal streptokinase in either the sera or renal biopsy specimens of patients with acute poststreptococcal glomerulonephritis.
Glomerular localization of platelet factor 4 in streptococcal nephritis.
Hepatitis C virus and renal transplant
Small nuclear ribonucleoprotein polypeptides in rat sperm
Age influence on mononuclear phagocyte system Fc-receptor function in poststreptococcal nephritis
Idiopathic membranous nephropathy associated with HLA-DRw3 and not related to monocyte-phagocyte system Fc receptor dysfunction, in father and son.
Decrease in mean platelet survival time in acute poststreptococcal glomerulonephritis (APSGN).
External iliac artery rupture as a manifestation of aspergillosis in a renal transplant recipient
Clinical course in 51 patients with idiopathic membranous glomerulopathy
Presence of circulating immune complexes in the classic form of hemolytic uremic syndrome: a constant finding.
[Kallikrein excretion in patients with nephritic and nephrotic syndromes
Atrial natriuretic factor
RENAL-FUNCTION IN FULL-TERM NEWBORNS FOLLOWING NEONATAL ASPHYXIA - A PROSPECTIVE-STUDY
IMMUNE THROMBOCYTOPENIC PURPURA ASSOCIATED WITH HEPATITIS-A
Incidence of circulating immune complexes in patients with acute poststreptococcal glomerulonephritis and in patients with streptococcal impetigo
Analysis of a teaching-learning model with adult ambulatory patients
Actividad de Calicreina Urinaria en Síndrome Hipoaldosteronismo Hiporeninémico.
Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia
Detection of circulating immune complexes by immunoenzyme assay with solid phase Clq
Glomerulopathies: pathogenic and developmental aspects
Focal segmental glomerulosclerosis. Clinical and histopathologic study in 14 patients
Antibody production and antigenic specific suppression to bovine serum albumin in uremic rats
Acute diffuse poststreptococcal glomerulonephritis. Clinical, histopathological and follow-up study
Idiopathic rapidly progressive glomerulonephritis treated with high-dose methylprednisolone
Acute renal failure due to post anesthetic rabdomyolysi
Idiopathic membranous glomerulonephropathy. Clinical and histologic aspects in 10 cases

Abstract (8)

GREMLIN REGULATES RENAL INFLAMMATION VIA VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 PATHWAY
TUBULAR OVEREXPRESSION OF GREMLIN IN TRANSGENIC MICE AGGRAVATES RENAL DAMAGE IN DIABETIC NEPHROPATHY
GREMLIN MODULATES FIBROSIS IN RENAL CELLS VIA VEGFR2 PATHWAY AND INDEPENDENT OF ITS BMPS ANTAGONISTS EFFECTS
DIFFERENTIAL REGULATION BY ANGIOTENSIN II AND TGF-B1 OF NOTCH SIGNALING IN THE KIDNEY
Angiotensin II causes epithelial mesenchymal transdifferentiation via activation of Smad and MAPK signaling pathways
Expression of gremlin in diabetic nephropathy in vivo and epithelial-mesenchymal transdifferentiation in vitro.
Combined treatment with angiotensin type 1 and type 2 receptor antagonists blocked NF-KB pathway and renal inflammatory infiltration
Renal kallikrein-kinin system (KK) compromise in a 5/6 renal ablation model modulated by mycophenolate mofetil (MMF).

BookSection (8)

Postinfectious Glomerulonephritis
Inmunosupresores e inmunorreguladores en enfermedad renal
Nefropatía Crónica del Injerto
Post-infectious glomerulonephritis
Glomerulopatías Primarias
Nefropatía membranosa
Pathogenesis of Glomerular Disease.
Anti-Neutrophil Cytoplasmic Autoantibodies (ANCA) in Poststreptococcal Nephritis (APSGN).

BookWhole (2)

Molecular Regulation of Notch Signaling by Gremlin
Regulation of vascular and renal cells by common mediators in health and disease: Role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease

Editorial (2)

Diabetic renal disease: The world kidney day in Chile [Enfermedad renal en la diabetes: A propósito del día mundial del riñón]
Enfermedad renal en la diabetes: A propósito del día mundial del riñón

EditorialMaterial (1)

Diabetic renal disease: The World Kidney Day in Chile

Letter (1)

Response to Yoshizawa et al.

Proyecto (7)

GREMLIN: UN MEDIADOR PROFIBROTICO Y PROINFLAMATORIO INVOLUCRADO EN LA NEFROPATIA DIABETICA.
GREMLIN: ¿UN NUEVO BIOMARCADOR RENAL PROFIBROTICO? SU ROL EN PATOLOGÍA RENAL HUMANA Y EXPERIMENTAL.
FIBROSIS RENAL: ESTUDIO DE NUEVOS MEDIADORES DE TRANSDIFERENCIACIÓN EPITELIO-MESENQUIMAL (TEM).
ESTUDIO DE LA TRANSDIFERENCIACION TUBULO-EPITELIAL EN ENFERMEDAD RENAL PROGRESIVA. ROL DE LA PROTEINURIA Y ANGIOTENSINA II
Estudio de la Transdiferenciacion tubulo-epitelial en la enfermedad renal progresiva. Rol de la proteinuria y angiotensina II
ESTUDIO DE LA TRANSDIFERENCIACIÓN TUBULO-EPITELIAL EN ENFERMEDAD RENAL PROGRESIVA. ROL DE LA PROTEINURIA Y ANGIOTENSINA II.
Determinación in situ de Factores de Transcripción activados (NF-kB y AP1) y estudio de mecanismos apoptoticos en glomerulopatias proteinuricas

Review (8)

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
Could Notch signaling pathway be a potential therapeutic option in renal diseases?
Targeting inflammation in diabetic nephropathy: a tale of hope
Rol del riñón en la hipertensión sal-sensible
Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage
Daño vascular en la enfermedad renal crónica
Vascular damage in chronic kidney disease
Chronic kidney disease: Classification, mechanisms of progression and strategies for renoprotection
176
Sergio Mezzano

Catedratico

Medicina

Universidad Austral de Chile

Valdivia, Chile

23
Leopoldo Ardiles

Profesor Titular

Medicina

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

14
Carolina Lavoz

Investigador principal

Medicina

Universidad Austral de Chile

Valdivia, Chile

7
J Daniel Carpio

Director Ejecutivo-Profesor Asociado

Unidad Microscopía Electrónica

Universidad Austral de Chile

Valdivia, Chile

7
Claudio Flores

Académico

Medicina

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

4
INGRID EHRENFELD

FULL PROFESSOR

ANATOMIA; HISTOLOGIA & PATOLOGIA

UNIVERSIDAD AUSTRAL DE CHILE

VALDIVIA, Chile

3
Maria Droguett

Profesor Asociado

Medicina

Universidad Austral de Chile

Valdivia, Chile

3
Lucas Opazo

Postdoctoral Fellow

Renal, Vascular and Diabetes Research Lab

Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Madrid, España

3
Carlos Figueroa

Head

Anatomy, Histology and Pathology

Universidad Austral de Chile

Valdivia, Chile

2
Paola Krall

Profesor Auxiliar

Universidad Austral de Chile

Valdivia, Chile

2
ARELI CÁRDENAS

Académica e Investigadora

Universidad Bernardo O'Higgins

Santiago, Chile

1
Daniel Cabrera

Investigador Adjunto

Gastroenterología

Pontificia Universidad Catolica de Chile

santiago, Chile

1
Maria Escobar

Consultora en Enfermedades no Transmisibles

Organización Panamericana de la Salud

Santiago, Chile

1
Eileen Blackburn

Médico Jefe de Laboratorio Clínico

Servicio de Laboratorio Clínico

Hospital Base Valdivia

Valdivia, Chile

1
Enrique Brandan

Profesor Titular

Biología Celular y Molecular

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
ricardo fadic

Jefe de Division

Division de Neurociencias

DEPARTAMENTO DE NEUROLOGÍA, FACULTAD DE MEDICINA, P. UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Jaime Gutierrez

Associate Professor and Researcher

Tecnología Médica

Universidad San Sebastián

Santiago, Chile

1
Claudio Cabello

Full Professor

Ciencias Biologicas

UNIVERSIDAD ANDRES BELLO

Santiago, Chile

1
Anita Plaza

Investigador

Medicina

Universidad Austral de Chile

Valdivia, Chile

1
Antonio Vukusich

Decano Facultad de Medicina

Facultad de Medicina

Universidad de Los Andes

Santiago, Chile

1
Carlos Vio

Profesor

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
PABLO TRONCOSO

Profesor Asociado

Urología

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

1
Miguel Barria

Académico

Inmunología y Parasitología

Universidad Austral de Chile

Valdivia, Chile